Pittman C, Plitt S, Birse T, Doucette K, Romanowski B, Cooper R, et al. Prevalence and correlates of HIV and hepatitis B virus coinfection in northern Alberta. Canadian J Infect Dis Med Microbiol. 2014;25(1):e8–e13.
Google Scholar
Bourgeois A, Edmunds M, Awan A, Jonah L, Varsaneux O, Siu W. Can we eliminate HIV?: HIV in Canada—surveillance report, 2016. Can Commun Dis Rep. 2017;43(12):248.
CAS
PubMed
PubMed Central
Google Scholar
Puoti M, Airoldi M, Bruno R, Zanini B, Spinetti A, Pezzoli C, et al. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev. 2002;4(1):27–35.
PubMed
Google Scholar
Gillis J, Cooper C, Rourke S, Rueda S, O’Brien K, Collins E, et al. Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals. Qual Life Res. 2013;22(7):1525–35.
PubMed
Google Scholar
Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44:S6–9.
PubMed
Google Scholar
Spradling P, Richardson J, Buchacz K, Moorman A, Brooks J, Investigators HOS. Prevalence of chronic hepatitis B virus infection among patients in the HIV outpatient study, 1996–2007. J Viral Hepat. 2010;17(12):879–86.
CAS
PubMed
Google Scholar
Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Muñoz A, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the multicenter cohort study (MACS). Lancet. 2002;360(9349):1921–6.
PubMed
Google Scholar
Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42(6):799–805.
CAS
PubMed
Google Scholar
Marin B, Thiébaut R, Bucher HC, Rondeau V, Costagliola D, Dorrucci M, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS (London, England). 2009;23(13):1743.
Google Scholar
Hoffmann CJ, Seaberg EC, Young S, Witt MD, D’Acunto K, Phair J, et al. Hepatitis B and long-term HIV outcomes in co-infected HAART recipients. AIDS (London, England). 2009;23(14):1881.
Google Scholar
Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. Aids. 1997;11(5):597–606.
CAS
PubMed
Google Scholar
Konopnicki D, Mocroft A, De Wit S, Antunes F, Ledergerber B, Katlama C, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. Aids. 2005;19(6):593–601.
PubMed
Google Scholar
Nikolopoulo GK, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, Zavitsanos X, et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis. 2009;48(12):1763–71.
Google Scholar
Canada PHAo. In: Brief report: hepatitis B infection in Canada; 2011.
Palmer AK, Klein MB, Raboud J, Cooper C, Hosein S, Loutfy M, et al. Cohort profile: the Canadian observational cohort collaboration. Int J Epidemiol. 2010;40(1):25–32.
PubMed
Google Scholar
Al-Mohri H, Cooper C, Murphy T, Klein M. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV medicine. 2005;6(6):375–8.
CAS
PubMed
Google Scholar
Shaheen AAM, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C–related fibrosis: a systematic review. Hepatol. 2007;46(3):912–21.
Google Scholar
Wu SD, Wang JY, Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study. World J Gastroenterol. 2010;16(4):501–7.
CAS
PubMed
PubMed Central
Google Scholar
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatol. 2003;38(2):518–26.
Google Scholar
Ward M, Buehler MJW, Jaffe MHW, Berkelman RL. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults; 1993.
Google Scholar
Wandeler G, Gsponer T, Bihl F, Bernasconi E, Cavassini M, Kovari H, et al. Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. J Infect Dis. 2013;208(9):1454–8.
CAS
PubMed
Google Scholar
Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV cohort study. Lancet. 2000;356(9244):1800–5.
CAS
PubMed
Google Scholar
Soriano V, Puoti M, Bonacini M, Brook G, Cargnel A, Rockstroh J, et al. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV–HBV international panel. Aids. 2005;19(3):221–40.
PubMed
Google Scholar
Statement on Hepatitis B Virus Vaccine. Health Welf Can. 1982:221–4.
Macdonald N. Moving towards a universal hepatitis B vaccine program for Canadian children. Can J Infect Dis. 1995;6(3):129–30.
CAS
PubMed
PubMed Central
Google Scholar
Zhang J, Zou S, Giulivi A. Epidemiology of hepatitis B in Canada. Can J Infect Dis. 2001;12(6):345–50.
CAS
PubMed
PubMed Central
Google Scholar
Osiowy C, Giles E, Trubnikov M, Choudhri Y, Andonov A. Characterization of acute and chronic hepatitis B virus genotypes in Canada. PLoS One. 2015;10(9):e0136074.
PubMed
PubMed Central
Google Scholar
Kellerman SE, Hanson DL, McNaghten A, Fleming PL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus–infected subjects. J Infect Dis. 2003;188(4):571–7.
PubMed
Google Scholar
Al-Mohri H, Murphy T, Lu Y, Lalonde RG, Klein MB. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker. JAIDS J Acquir Immune Defic Syndr. 2007;44(4):463–9.
PubMed
Google Scholar
Lincoln D, Petoumenos K, Dore G, Database AHO. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV med. 2003;4(3):241–9.
CAS
PubMed
Google Scholar
Phung B-C, Sogni P, Launay O. Hepatitis B and human immunodeficiency virus co-infection. World J Gastroenterol: WJG. 2014;20(46):17360.
PubMed
Google Scholar
Andonov A, Butler G, Ling R, Prichard L, Baril J, Gale-Rowe M. Primary care management of hepatitis B–quick reference (HBV-QR); 2013.
Google Scholar
Terrault NA, Lok AS, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatol. 2018;67(4):1560–99.
Google Scholar
Thio CL, Smeaton L, Saulynas M, Hwang H, Saravan S, Kulkarni S, et al. Characterization of HIV-HBV co-infection in a multi-national HIV-infected cohort. AIDS (London, England). 2013;27(2):191.
CAS
Google Scholar
Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C. Hepatitis B virus co-infection impacts baseline HIV parameters and HAART-related hepatotoxicity risk in an HIV-infected Nigerian cohort. Clin Infect Dis. 2007;49(8):1268–73.
Google Scholar
Hawkins C, Christian B, Ye J, Nagu T, Aris E, Chalamilla G, et al. Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania. Aids. 2013;27(6):919–27.
CAS
PubMed
Google Scholar
Sarkar J, Saha D, Bandyopadhyay B, Saha B, Kedia D, Mazumder DG, et al. Baseline characteristics of HIV & hepatitis B virus (HIV/HBV) co-infected patients from Kolkata, India. Indian J Med Res. 2016;143(5):636.
CAS
PubMed
PubMed Central
Google Scholar
Wondimeneh Y, Alem M, Asfaw F, Belyhun Y. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar teaching hospital. Northwest Ethiop Virol j. 2013;10(1):171.
CAS
Google Scholar
Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. Aids. 2008;22(16):2135–41.
CAS
PubMed
Google Scholar
Piroth L, Grappin M, Cuzin L, Mouton Y, Bouchard O, Raffi F, et al. Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients. J Viral Hepat. 2000;7(4):302–8.
CAS
PubMed
Google Scholar
De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, et al. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med. 2002;162(18):2125–32.
PubMed
Google Scholar
Rockstroh J, Konopnicki D, Soriano V, Kirk O, Antunes F, Knysz B, et al. Hepatitis B and hepatitis C in the EuroSIDA cohort: prevalence and effect on mortality, AIDS, progression and response to HAART. In: 11th conference on retroviruses and opportunistic infections; 2004.
Google Scholar
Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. Jama. 2002;288(2):199–206.
PubMed
Google Scholar
Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. Aids. 2004;18(15):2039–45.
PubMed
Google Scholar
Amin J, Kaye M, Skidmore S, Pillay D, Cooper D, Dore G. HIV and hepatitis C coinfection within the CAESAR study. HIV medicine. 2004;5(3):174–9.
CAS
PubMed
Google Scholar
Hull MW, Rollet K, Odueyungbo A, Saeed S, Potter M, Cox J, et al. Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis. 2012;54(12):1798–805.
CAS
PubMed
Google Scholar
Shmagel KV, Saidakova EV, Shmagel NG, Korolevskaya LB, Chereshnev VA, Robinson J, Grivel JC, Douek DC, Margolis L, Anthony DD, Lederman MM. Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection. HIV Med. 2016;17(8):581–9. https://doi.org/10.1111/hiv.12357.
CAS
PubMed
PubMed Central
Google Scholar
Mandorfer M, Reiberger T, Payer B, Peck-Radosavljevic M, HIV V, Group LS. The influence of portal pressure on the discordance between absolute CD4+ cell count and CD4+ cell percentage in HIV/hepatitis C virus–Coinfected patients. Clin Infect Dis. 2013;56(6):904–5.
CAS
PubMed
Google Scholar
Wandeler G, Mulenga L, Vinikoor MJ, Kovari H, Battegay M, Calmy A, et al. Liver fibrosis in treatment-naive HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared. Int J Infect Dis. 2016;51:97–102.
PubMed
PubMed Central
Google Scholar
Price JC, Seaberg EC, Badri S, Witt MD, D’acunto K, Thio CL. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis. 2012;205(6):1005–13.
CAS
PubMed
PubMed Central
Google Scholar
Boyd A, Lasnier E, Molina JM, Lascoux-Combe C, Bonnard P, Miailhes P, et al. Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use. Antivir Ther. 2010;15(7):963.
CAS
PubMed
Google Scholar
Stockdale AJ, Phillips RO, Beloukas A, Appiah LT, Chadwick D, Bhagani S, et al. Liver fibrosis by transient elastography and virologic outcomes after introduction of tenofovir in lamivudine-experienced adults with HIV and hepatitis B virus coinfection in Ghana. Clin Infect Dis. 2015;61(6):883–91.
CAS
PubMed
Google Scholar
Vinikoor MJ, Sinkala E, Chilengi R, Mulenga LB, Chi BH, Zyambo Z, et al. Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia. Clin Infect Dis. 2017;64(10):1343–9.
CAS
PubMed
PubMed Central
Google Scholar
Audsley J, Robson C, Aitchison S, Matthews GV, Iser D, Sasadeusz J, Lewin SR. Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy. Open Forum Infect Dis. 2016;3(1):ofw035. https://doi.org/10.1093/ofid/ofw035.
PubMed
PubMed Central
Google Scholar
Puoti M, Cozzi-Lepri A, Arici C, Moller N, Lundgren J, Ledergerber B, et al. Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg-and HIV-positive individuals: results from an inter-cohort analysis. Antivir Ther. 2006;11(5):567–74.
CAS
PubMed
Google Scholar
Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J. Lewin SR. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS (London, England). 2017;31(15):2035–52.
Google Scholar
Audsley J, Seaberg EC, Sasadeusz J, Matthews GV, Avihingsanon A, Ruxrungtham K, et al. Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART. PLoS One. 2011;6(11):e26482.
CAS
PubMed
PubMed Central
Google Scholar
Ryom L, Lundgren JD, De Wit S, Kovari H, Reiss P, Law M, et al. Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons. Aids. 2016;30(11):1731–43.
CAS
PubMed
Google Scholar
Glässner A, Eisenhardt M, Kokordelis P, Krämer B, Wolter F, Nischalke HD, et al. Impaired CD4+ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients. J Hepatol. 2013;59(3):427–33.
PubMed
Google Scholar
Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, et al. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection. J Virol. 2009;83(15):7649–58.
CAS
PubMed
PubMed Central
Google Scholar
Boyd A, Bottero J, Miailhes P, Lascoux-Combe C, Rougier H, Girard PM, et al. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV–HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study. J Int AIDS Soc. 2017;20(1):21426.
PubMed
PubMed Central
Google Scholar
Thornton AC, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, et al. Hepatitis B, hepatitis C, and mortality among HIV-positive individuals. AIDS (London, England). 2017;31(18):2525.
Google Scholar
Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, et al. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis. AIDS Patient Care STDs. 2012;26(2):73–80.
PubMed
PubMed Central
Google Scholar